Study hints at new target to improve immune therapy in triple-negative breast cancer

by CU Anschutz Medical CampusHeide Ford, PhD, and University of Colorado Cancer Center colleagues show that Eya3 may regulate immune response to triple-negative breast cancer, potentially improvi

Updated on: June 01,2024

Study hints at new target to improve immune therapy in triple-negative breast cancer

by CU Anschutz Medical CampusHeide Ford, PhD, and University of Colorado Cancer Center colleagues show that Eya3 may regulate immune response to triple-negative breast cancer, potentially improvi

Updated on:June 01,2024

Redesigning the diagnostic screening process for colorectal cancer

by Alistair Jones,Singapore Management UniversityCredit: Anna Tarazevich from PexelsDuring recent decades, the incidence of colorectal cancer (CRC) has been rising globally and its prevalence in

Updated on: September 07,2024

Redesigning the diagnostic screening process for colorectal cancer

by Alistair Jones,Singapore Management UniversityCredit: Anna Tarazevich from PexelsDuring recent decades, the incidence of colorectal cancer (CRC) has been rising globally and its prevalence in

Updated on:September 07,2024

In the lab and in the clinic, alisertib with TAK-228 excels against solid tumors

by CU Anschutz Medical CampusUniversity of Colorado Cancer Center investigator, Jennifer Diamond, MD, and colleagues report promising phase I results of alisertib with TAK-228 against solid tumor

Updated on: April 22,2024

In the lab and in the clinic, alisertib with TAK-228 excels against solid tumors

by CU Anschutz Medical CampusUniversity of Colorado Cancer Center investigator, Jennifer Diamond, MD, and colleagues report promising phase I results of alisertib with TAK-228 against solid tumor

Updated on:April 22,2024

Osimertinib with savolitinib demonstrates stronger efficacy than osimertinib alone in some patients

by International Association for the Study of Lung CancerCredit: Unsplash/CC0 Public DomainThe combination of osimertinib and savolitinib showed clinically meaningful improvement in objective response

Updated on: September 27,2024

Osimertinib with savolitinib demonstrates stronger efficacy than osimertinib alone in some patients

by International Association for the Study of Lung CancerCredit: Unsplash/CC0 Public DomainThe combination of osimertinib and savolitinib showed clinically meaningful improvement in objective response

Updated on:September 27,2024

Aumolertinib shows improved progression-free survival in stage III non-small cell lung cancer

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe epidermal growth factor receptor tyrosine kinase inhibitor aumolertinib demonstrated improved progression-

Updated on: September 27,2024

Aumolertinib shows improved progression-free survival in stage III non-small cell lung cancer

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe epidermal growth factor receptor tyrosine kinase inhibitor aumolertinib demonstrated improved progression-

Updated on:September 27,2024

Beating by overheating: A new strategy to combat cancer

byNetherlands Cancer InstituteOne could compare cancer cells subjected to the paradoxial approach in this study to the engine of a racing car: if you crank up the RPM and then turn off the cooli

Updated on: March 30,2024

Beating by overheating: A new strategy to combat cancer

byNetherlands Cancer InstituteOne could compare cancer cells subjected to the paradoxial approach in this study to the engine of a racing car: if you crank up the RPM and then turn off the cooli

Updated on:March 30,2024

Researchers discover enzyme's role in 'natural killer T cell lymphoma'

by National University of SingaporeThese findings potentiate an alternative treatment strategy for this aggressive disease. Credit: NUSNatural killer T cell lymphoma (NKTL) is an aggressive form

Updated on: June 19,2024

Researchers discover enzyme's role in 'natural killer T cell lymphoma'

by National University of SingaporeThese findings potentiate an alternative treatment strategy for this aggressive disease. Credit: NUSNatural killer T cell lymphoma (NKTL) is an aggressive form

Updated on:June 19,2024

Study: Tumor necroptosis promotes metastasis by modulating tumor-host immunity

by Impact Journals LLCTumor necroptosis promotes metastasis of breast cancer by suppressing anti-tumor immunity. Credit: 2023 Liu et al.A new editorial paper was published inOncotarget's&nbs

Updated on: February 01,2024

Study: Tumor necroptosis promotes metastasis by modulating tumor-host immunity

by Impact Journals LLCTumor necroptosis promotes metastasis of breast cancer by suppressing anti-tumor immunity. Credit: 2023 Liu et al.A new editorial paper was published inOncotarget's&nbs

Updated on:February 01,2024

Researchers look to the gut to boost cancer immunotherapy's fighting power

by Harvard Medical SchoolCredit: Pixabay/CC0 Public DomainCancer immunotherapy has transformed the treatment of many types of cancer. Yet, for reasons that remain poorly understood, not all patie

Updated on: January 30,2024

Researchers look to the gut to boost cancer immunotherapy's fighting power

by Harvard Medical SchoolCredit: Pixabay/CC0 Public DomainCancer immunotherapy has transformed the treatment of many types of cancer. Yet, for reasons that remain poorly understood, not all patie

Updated on:January 30,2024

'Hijacker' drives cancer in some patients with high-risk neuroblastoma

by St. Jude Children's Research HospitalThe study authors (from left) Ying Shao, Yu Liu, PhD, and John Easton, PhD. Credit: Seth Dixon / St. Jude Children's Research HospitalResearchers h

Updated on: March 13,2024

'Hijacker' drives cancer in some patients with high-risk neuroblastoma

by St. Jude Children's Research HospitalThe study authors (from left) Ying Shao, Yu Liu, PhD, and John Easton, PhD. Credit: Seth Dixon / St. Jude Children's Research HospitalResearchers h

Updated on:March 13,2024

Infections from a diarrhea-causing parasite are on the rise in the UK, but experts aren't quite sure why

by Paul Hunter,The ConversationLaboratory notifications of Cryptosporidium species in England, Wales and Northern Ireland, by week of specimen, 2023. Credit:Eurosurveillance(2023). D

Updated on: April 20,2024

Infections from a diarrhea-causing parasite are on the rise in the UK, but experts aren't quite sure why

by Paul Hunter,The ConversationLaboratory notifications of Cryptosporidium species in England, Wales and Northern Ireland, by week of specimen, 2023. Credit:Eurosurveillance(2023). D

Updated on:April 20,2024

Climbing a new path allows chemists to ascend cancer's steepest research challenge, a gene called MYC

byUniversity of FloridaA "fishing hook" molecule in red is added to a drug-like compound to catch enzymes that chop up RNA, yellow, for recycling by cells. The strategy has been used t

Updated on: January 16,2024

Climbing a new path allows chemists to ascend cancer's steepest research challenge, a gene called MYC

byUniversity of FloridaA "fishing hook" molecule in red is added to a drug-like compound to catch enzymes that chop up RNA, yellow, for recycling by cells. The strategy has been used t

Updated on:January 16,2024